Dr. R. Mahoney, Neurology

14 miles from site 03

✓ Patient enrolled in 2 CNS trials

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Book a demo

Ask the map

Dr. R. Mahoney, Neurology

14 miles from site 03

✓ Patient enrolled in 2 CNS trials

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Book a demo

Ask the map

Dr. R. Mahoney, Neurology

14 miles from site 03

✓ Patient enrolled in 2 CNS trials

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Book a demo

Ask the map

Dr. R. Mahoney, Neurology

14 miles from site 03

✓ Patient enrolled in 2 CNS trials

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Book a demo

Ask the map

Dr. R. Mahoney, Neurology

14 miles from site 03

✓ Patient enrolled in 2 CNS trials

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Book a demo

Ask the map

Dr. R. Mahoney, Neurology

14 miles from site 03

✓ Patient enrolled in 2 CNS trials

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Book a demo

Ask the map

Dr. R. Mahoney, Neurology

14 miles from site 03

✓ Patient enrolled in 2 CNS trials

Patients for your trial, found.

We find the physicians who have your patients and get them into your trial.

Book a demo

Ask the map

Every breakthrough should reach the people it was made for.

Every breakthrough should reach the people it was made for.

Every breakthrough should reach the people it was made for.

Every breakthrough should reach the people it was made for.

Every breakthrough should reach the people it was made for.

Every breakthrough should reach the people it was made for.

Four in five trials miss their enrollment timeline. The patients exist. The physicians who see them are twenty minutes from the site and have never heard of the study.

Ads find strangers. Patients say they would hear about a trial from their own doctor, not a banner. A screener full of strangers is not enrollment.

So we mapped every US physician: what they treat, where they send patients, where those patients live. Then we do the asking, in your name.

Every effective drug had to be tested in someone. Somewhere in the country, that person already exists and already has a doctor. We are building the layer between the two, so that no trial waits on people who were never told, and no patient waits on a breakthrough that already exists.

How it works

How it works

01

Share the trial protocol.

Protocol, site addresses, target enrollment. A PDF is enough. The surfacing agent returns the ranked physicians for each site, with the reason each one is on the list.

02

We find physicians who have your patients.

The outreach agent reaches them by email and phone, in your name. The ask is specific: which of their patients likely qualify and why. Your coordinator joins when a physician is ready.

03

Patients start enrolling.

Patients arrive at the site the way they always have, with a heads-up before each one. A new list every day: who was reached, who replied, who sent patients, which site needs help next.

No PHI leaves the practice. Spellbinder works at the physician level.

HIPAA compliant. Outreach copy MLR approved.

Nothing to install. Exports to your CTMS on request.

What we built

A map of every US physician and two agents that work it. Nobody on your team builds a list, writes an email or chases a reply.

Healthcare Map

Every US physician, resolved from 400+ sources to one profile: what they treat, whom they send patients to, where those patients live, and which trials they have enrolled into before.

Agents

Two agents work the map. The surfacing agent reads your protocol and sites and delivers a ranked list per site every morning, with the reason each physician is on it. The outreach agent runs the conversation in your name, follows up, logs every reply and hands the physician to your coordinator when they say yes.

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

From protocol to enrolled, in order.

Site feasibility

Eligible-patient estimates by metro, health system and physician, built from the inclusion/exclusion criteria before you sign a single site. See where the patients already are, and where competing trials are already pulling from.

Investigator identification

Patient recruitment

Enrollment tracking

10 physicians identified today
Tap to view your day's targets · 88 miles total
now

Today

7 visits · 88 miles

Dr. Alex M Vera

Urology
First VisitEarly Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity

Dr. Richard Lang

Internal Medicine
First VisitKey Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement

Dr. Jane Green

Internal Medicine — Infectious Disease
First VisitKey Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest

Dr. Karim Mohammed

Internal Medicine — Infectious Disease
Third VisitKey Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion

What is on the map

Any indication. Especially the rare ones.

Any indication. Especially the rare ones.

1.2M physicians, 7.1M providers and 1.9M organizations-, one profile each from 400+ sources. If a patient exists, so does their doctor, and they are on the map.

1.2M physicians, 7.1M providers and 1.9M organizations-, one profile each from 400+ sources. If a patient exists, so does their doctor, and they are on the map.

Psychiatry

41,000 physicians

Cardiology

33,200 physicians

Endocrinology

26,900 physicians

Oncology

21,700 physicians

Neurology

18,400 physicians

Huntington’s

68 HDSA centers

Duchenne

38 certified care centers

Cystic fibrosis

130+ accredited centers

Pulmonary arterial hypertension

107 accredited centers

Spinal muscular atrophy

29 care center sites

Rett syndrome

20 centers of excellence

Myasthenia gravis

13,900 neurologists

Sickle cell disease

19,900 hematologists

IgA nephropathy

11,600 nephrologists

Eosinophilic esophagitis

15,700 gastroenterologists

Hidradenitis suppurativa

12,800 dermatologists

Fabry disease

Under 2,500 medical geneticists

Grey blocks are sized by physicians on the map. Pink blocks are rare indications, with the accredited centers or the specialty that treats them.

Grey blocks are sized by physicians on the map. Pink blocks are rare indications, with the accredited centers or the specialty that treats them.

Showing 17 of 400+ specialties and indications

Showing 17 of 400+ specialties and indications

83%

83%

83%

83%

of patients identified were interested and referred, because the ask came from their own physician, not an ad.

of patients identified were interested and referred, because the ask came from their own physician, not an ad.

Trusted by experts at pharmaceutical companies

“Our coordinators had spent a month finding one physician. Spellbinder gave us three in forty-eight hours. We signed before the contract was drafted.”

Clinical Operations Lead

Clinical-stage biopharma

One healthcare map for biopharma

The same physician profiles, care patterns and outreach engine serve the clinical team filling a trial and the commercial team preparing a launch.

The same physician profiles, care patterns and outreach engine serve the clinical team filling a trial and the commercial team preparing a launch.

For clinical

Spellbinder finds the physicians who already have your patients, near every site, and reaches them in your name.

For commercial

Spellbinder finds the prescribers you have not reached, the paths into a territory, and the KOLs whose behaviour is shifting.